The American Society of Clinical Oncology (ASCO) recently reported major scientific advances in the following areas: new therapy options for hard-to-treat lung and pancreatic cancers; FDA drug approvals for women with advanced breast cancer that does not express the HER2 gene (the majority of breast cancers) and people with chronic lymphocytic leukemia (a cancer with ... More